Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Med Chem
2013 May 23;5610:4071-81. doi: 10.1021/jm400346a.
Show Gene links
Show Anatomy links
Development of 2'-substituted (2S,1'R,2'S)-2-(carboxycyclopropyl)glycine analogues as potent N-methyl-d-aspartic acid receptor agonists.
Risgaard R
,
Nielsen SD
,
Hansen KB
,
Jensen CM
,
Nielsen B
,
Traynelis SF
,
Clausen RP
.
???displayArticle.abstract???
A series of 2'-substituted analogues of the selective NMDA receptor ligand (2S,1'R,2'S)-2-(carboxycyclopropyl)glycine ((S)-CCG-IV) have been designed, synthesized, and pharmacologically characterized. The design was based on a docking study hypothesizing that substituents in the 2'-position would protrude into a region where differences among the NMDA receptor GluN2 subunits exist. Various synthetic routes were explored, and two different routes provided a series of alkyl-substituted analogues. Pharmacological characterization revealed that these compounds are NMDA receptor agonists and that potency decreases with increasing size of the alkyl groups. Variations in agonist activity are observed at the different recombinant NMDA receptor subtypes. This study demonstrates that it is possible to introduce substituents in the 2'-position of (S)-CCG-IV while maintaining agonist activity and that variation among NMDA receptor subtypes may be achieved by probing this region of the receptor.
???displayArticle.pubmedLink???
23614571
???displayArticle.pmcLink???PMC3689883 ???displayArticle.link???J Med Chem ???displayArticle.grants???[+]
Armstrong,
Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
2000, Pubmed
Armstrong,
Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
2000,
Pubmed
Armstrong,
Structure of a glutamate-receptor ligand-binding core in complex with kainate.
1998,
Pubmed
Braitman,
Inhibition of [3H]kainic acid receptor binding by divalent cations correlates with ion affinity for the calcium channel.
1987,
Pubmed
Bräuner-Osborne,
Ligands for glutamate receptors: design and therapeutic prospects.
2000,
Pubmed
Christopoulos,
Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log.
1998,
Pubmed
Clausen,
N-Hydroxypyrazolyl glycine derivatives as selective N-methyl-D-aspartic acid receptor ligands.
2008,
Pubmed
,
Xenbase
Clausen,
The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
2004,
Pubmed
Concellón,
Stereospecific cyclopropanation of highly substituted C-C double bonds promoted by CrCl2. Stereoselective synthesis of cyclopropanecarboxamides and cyclopropyl ketones.
2007,
Pubmed
Crimmins,
Formal synthesis of 6-deoxyerythronolide B.
2006,
Pubmed
Dias,
Total synthesis of the potent antitumor polyketide (-)-callystatin A.
2005,
Pubmed
Donevan,
The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors.
1998,
Pubmed
,
Xenbase
Erreger,
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
2007,
Pubmed
,
Xenbase
Erreger,
Glutamate receptor gating.
2004,
Pubmed
Furukawa,
Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
2003,
Pubmed
Furukawa,
Subunit arrangement and function in NMDA receptors.
2005,
Pubmed
Hansen,
Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements.
2008,
Pubmed
,
Xenbase
Hansen,
Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.
2011,
Pubmed
,
Xenbase
Hermit,
Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptors.
2004,
Pubmed
Honoré,
Complex structure of quisqualate-sensitive glutamate receptors in rat cortex.
1985,
Pubmed
Javitt,
Glutamate as a therapeutic target in psychiatric disorders.
2004,
Pubmed
Lifchits,
Catalytic asymmetric epoxidation of alpha-branched enals.
2010,
Pubmed
Mayer,
Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.
2005,
Pubmed
Naur,
Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.
2005,
Pubmed
Parsons,
Glutamate in CNS disorders as a target for drug development: an update.
1998,
Pubmed
Ransom,
Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines.
1988,
Pubmed
Riedel,
Glutamate receptor function in learning and memory.
2003,
Pubmed
Risgaard,
Partial agonists and subunit selectivity at NMDA receptors.
2010,
Pubmed
Sills,
[3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
1991,
Pubmed
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Traynelis,
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
1998,
Pubmed
,
Xenbase
